The role of alterations in BRCA1, BRCA2, TP53 and ATM genes in sporadic breast tumors

被引：0
|
作者：
Ticha, I. [1 ]
Soukupova, J. [1 ]
Janatova, M. [1 ]
Kleibl, Z. [1 ]
Pohlreich, P. [1 ]
机构：
[1] Charles Univ Prague, Fac Med 1, Inst Biochem & Expt Oncol, Prague, Czech Republic
来源：
EJC SUPPLEMENTS | 2008年 / 6卷 / 09期
关键词：
D O I：
10.1016/S1359-6349(08)71623-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：118 / 118
页数：1
相关论文
共 50 条
  • [1] Alterations in BRCA1, BRCA2, TP53 and ATM genes in sporadic breast tumours
    Prokopcova, J.
    Soukupova, J.
    Ticha, I.
    Janatova, M.
    Sevcik, J.
    Kleibl, Z.
    Kleiblova, P.
    Pohlreich, P.
    EJC SUPPLEMENTS, 2010, 8 (05): : 203 - 203
  • [2] Allelic loss at the BRCA1, BRCA2 and TP53 loci in human sporadic breast carcinoma
    Katsama, A
    Sourvinos, G
    Zachos, G
    Spandidos, DA
    CANCER LETTERS, 2000, 150 (02) : 165 - 170
  • [3] Loss of heterozygosity of BRCA1, BRCA2 and ATM genes in sporadic invasive ductal breast carcinoma
    Rio, PG
    Pernin, D
    Bay, JO
    Albuisson, E
    Kwiatkowski, F
    De Latour, M
    Bernard-Gallon, DJ
    Bignon, YJ
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1998, 13 (04) : 849 - 853
  • [4] Common variants in the ATM, BRCA1, BRCA2, CHEK2 and TP53 cancer susceptibility genes are unlikely to increase breast cancer risk
    Caroline Baynes
    Catherine S Healey
    Karen A Pooley
    Serena Scollen
    Robert N Luben
    Deborah J Thompson
    Paul DP Pharoah
    Douglas F Easton
    Bruce AJ Ponder
    Alison M Dunning
    Breast Cancer Research, 9
  • [5] Common variants in the ATM, BRCA1, BRCA2, CHEK2 and TP53 cancer susceptibility genes are unlikely to increase breast cancer risk
    Baynes, Caroline
    Healey, Catherine S.
    Pooley, Karen A.
    Scollen, Serena
    Luben, Robert N.
    Thompson, Deborah J.
    Pharoah, Paul D. P.
    Easton, Douglas F.
    Ponder, Bruce A. J.
    Dunning, Alison M.
    BREAST CANCER RESEARCH, 2007, 9 (02)
  • [6] Consistent TP53 mutations in BRCA1 and sporadic basal-like breast tumors, while infrequent in luminal BRCA1 tumors
    Manie, E.
    Vincent-Salomon, A.
    Lehmann-Che, J.
    Pierron, G.
    Turpin, E.
    Warcoin, M.
    Gruel, N.
    Lebigot, I
    Sastre-Garau, X.
    Delattre, O.
    de The, H.
    Stoppa-Lyonnet, D.
    Stern, M-H
    CANCER RESEARCH, 2009, 69 (02) : 271S - 271S
  • [7] Genomic deletions in the BRCA1, BRCA2 and TP53 regions associate with low expression of the estrogen receptor in sporadic breast carcinoma
    Schmutzler, RK
    Bierhoff, E
    Werkhausen, T
    Fimmers, R
    Speiser, P
    Kubista, E
    Krebs, D
    Zeillinger, R
    Wiestler, OD
    VonDeimling, A
    INTERNATIONAL JOURNAL OF CANCER, 1997, 74 (03) : 322 - 325
  • [8] Increased frequency of TP53 mutations in BRCA1 and BRCA2 ovarian tumours
    Ramus, SJ
    Bobrow, LG
    Pharoah, PDP
    Finnigan, DS
    Fishman, A
    Altaras, M
    Harrington, PA
    Gayther, SA
    Ponder, BAJ
    Friedman, LS
    GENES CHROMOSOMES & CANCER, 1999, 25 (02): : 91 - 96
  • [9] Preliminary investigation of the promoter methylation status of BRCA1, BRCA2 TP53 genes of some breast cancer patients
    Samuel, Titilola A.
    James, Babatunde Ayo
    Habeeb, Muhammad
    Oshodi, Temitope
    Magbagbeola, Olubunmi
    CANCER RESEARCH, 2016, 76
  • [10] High Frequency of TP53 Mutation in BRCA1 and Sporadic Basal-like Carcinomas but not in BRCA1 Luminal Breast Tumors
    Manie, Elodie
    Vincent-Salomon, Anne
    Lehmann-Che, Jacqueline
    Pierron, Gaelle
    Turpin, Elisabeth
    Warcoin, Mathilde
    Gruel, Nadege
    Lebigot, Ingrid
    Sastre-Garau, Xavier
    Lidereau, Rosette
    Remenieras, Audrey
    Feunteun, Jean
    Delattre, Olivier
    de The, Hugues
    Stoppa-Lyonnet, Dominique
    Stern, Marc-Henri
    CANCER RESEARCH, 2009, 69 (02) : 663 - 671
12345